Is Wegovy for life, or does treatment eventually stop?

Why weight tends to return when Wegovy stops

Obesity is a chronic condition, and the body actively defends its higher weight set-point through hormonal signals. Wegovy works by mimicking GLP-1, a gut hormone that signals fullness and reduces appetite. When the medicine is discontinued, those signals fade and hunger typically returns to baseline. A large study following STEP 1 participants found that roughly two-thirds of the weight lost during the 68-week trial had returned one year after stopping, with appetite and blood-sugar markers also reverting toward pre-treatment levels.

This pattern does not mean treatment has failed. It means weight is a condition that, for many people, needs ongoing management, in the same way blood pressure or cholesterol medication is continued for as long as the underlying condition exists. The Wegovy overview page covers the biology in more depth if that context is helpful.

Knowing this before starting treatment is genuinely useful: the decision to begin is also, in many cases, a decision to commit to something long-term, and if you want to understand whether Wegovy is typically taken for life, that page sets out the clinical picture honestly. A good prescriber will talk you through that honestly at the outset.

What the NHS and NICE say about duration, and how private treatment differs

Under NICE's technology appraisal TA875 for semaglutide, NHS use is capped at a maximum of two years within a specialist weight management service. That ceiling reflects NHS resource planning rather than a biological verdict that two years is the right stopping point for everyone. NICE also recommends reviewing progress at six months: if someone has not lost at least 5% of their body weight at the maintenance dose by that point, continuing is generally reconsidered.

Private treatment (including through a regulated online pharmacy) operates differently. There is no NICE-imposed time limit on private prescriptions. A GPhC-registered Independent Prescriber assesses each repeat clinically, considering how well treatment is working, what side effects (if any) are present, and whether the person's overall health picture supports continuing. Some patients do reach a point where their prescriber and they agree a planned, gradual stop makes sense; others stay on treatment indefinitely. Neither path is wrong.

If you are curious about how the cost of ongoing Wegovy treatment fits into a longer-term plan, that page sets out what to expect without hidden surprises.

Planned stopping versus gradual tapering

Stopping Wegovy is not usually done abruptly, a prescriber will typically guide a tapering plan if discontinuation is the decision, reducing dose in steps to observe how the body responds. This is the same logic that applies at the start: the dose escalation exists partly to let the digestive system adjust gradually, and stepping back down shows the same respect for physiology.

Some people stop because they have reached a stable, healthy weight and have built habits (diet, physical activity, sleep) that feel sustainable without pharmacological support. Others stop temporarily around surgery (telling the surgical team and anaesthetist is essential when you are on any GLP-1 medicine) or pregnancy. Wegovy is not recommended during pregnancy, breastfeeding, or when actively trying to conceive, the prescriber will advise on appropriate wash-out timing before conception is attempted. The Wegovy EMC information, which covers the full prescribing detail including contraindications, is worth reading if you want the clinical specifics on any of these points.

If you have a specific situation in mind, the FAQs cover several common scenarios, or you can get in touch with the clinical team directly.

Making the long-term decision with a prescriber you trust

The question of whether Wegovy is for life is one a lot of people sit with, and it deserves a straight answer rather than a deflection. For many (probably most) people who respond well and whose weight is primarily driven by biological factors, the honest answer is that long-term or indefinite use makes clinical sense, reviewed regularly. For others, a defined course with a planned exit is appropriate.

What responsible treatment looks like in practice: a prescriber who knows your full picture reviews your progress before every repeat. At nume, that review is carried out by a real clinician reading your answers personally, not automated software. There is no subscription model here, each repeat is a fresh clinical decision, which means nothing is continued on autopilot. Think of the pen sitting in the fridge door each week as a prompt that the relationship with your prescriber is an active one, not a standing order.

The question of whether people typically stay on Wegovy for life has its own dedicated page if you want to read further before deciding. When you are ready to start a proper conversation about whether treatment is right for you at all, our prescribers are the right people to have it with.

Wegovy is a prescription-only medicine. A prescriber assesses suitability before any treatment can be supplied. Start your free consultation to speak with our clinical team.